Cargando…
Protection against Respiratory Syncytial Virus Infection by DNA Immunization
Respiratory syncytial virus (RSV) remains a major cause of morbidity and mortality in infants and the elderly and is a continuing challenge for vaccine development. A murine T helper cell (Th) type 2 response associates with enhanced lung pathology, which has been observed in past infant trials usin...
Autores principales: | Li, Xiaomao, Sambhara, Suryaprakash, Li, Cindy Xin, Ewasyshyn, Mary, Parrington, Mark, Caterini, Judy, James, Olive, Cates, George, Du, Run-Pan, Klein, Michel |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
1998
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2213364/ https://www.ncbi.nlm.nih.gov/pubmed/9705950 |
Ejemplares similares
-
Adenoviral vector‐based platforms for developing effective vaccines to combat respiratory viral infections
por: Elkashif, Ahmed, et al.
Publicado: (2021) -
Immunosenescence and Influenza Vaccine Efficacy
por: Sambhara, Suryaprakash, et al.
Publicado: (2009) -
Vaccination of pregnant women with respiratory syncytial virus vaccine and
protection of their infants
por: Madhi, Shabir A, et al.
Publicado: (2020) -
Respiratory Syncytial Virus
por: Fraire, Armando E., et al.
Publicado: (2013) -
Respiratory syncytial virus
por: Ruuskanen, Olli, et al.
Publicado: (1993)